DRMAW vs MAS
Dermata Therapeutics Inc. Warrant (DRMAW) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
DRMAW currently screens at market cap $0. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the DRMAW and MAS stock pages for the full models.
Not investment advice.